Given the central role of monocyte-mediated inflammation in ischemic brain injury and the protective, anti-inflammatory functions of albumin, we hypothesized that a higher MAR would be related to worse 3-month functional outcomes after AIS. The gene discussed is ALB; the disease is androgen insensitivity syndrome.